Published in Toxicol Appl Pharmacol on August 31, 2012
Gut microbiome perturbations induced by bacterial infection affect arsenic biotransformation. Chem Res Toxicol (2013) 1.04
Maternal methyl supplemented diets and effects on offspring health. Front Genet (2014) 0.89
Maternal arsenic exposure and birth outcomes: a comprehensive review of the epidemiologic literature focused on drinking water. Int J Hyg Environ Health (2014) 0.87
The influence of early life nutrition on epigenetic regulatory mechanisms of the immune system. Nutrients (2014) 0.87
Relation between in Utero Arsenic Exposure and Birth Outcomes in a Cohort of Mothers and Their Newborns from New Hampshire. Environ Health Perspect (2016) 0.85
Select Prenatal Environmental Exposures and Subsequent Alterations of Gene-Specific and Repetitive Element DNA Methylation in Fetal Tissues. Curr Environ Health Rep (2015) 0.84
Epigenetics and nutritional environmental signals. Integr Comp Biol (2014) 0.80
Characterization of timed changes in hepatic copper concentrations, methionine metabolism, gene expression, and global DNA methylation in the Jackson toxic milk mouse model of Wilson disease. Int J Mol Sci (2014) 0.78
Evidence from clinical and animal model studies of the long-term and transgenerational impact of stress on DNA methylation. Semin Cell Dev Biol (2015) 0.78
Determinants of Orofacial Clefting I: Effects of 5-Aza-2(/)-deoxycytidine on Cellular Processes and Gene Expression during Development of the First Branchial Arch. Reprod Toxicol (2016) 0.76
Maternal blood cadmium, lead and arsenic levels, nutrient combinations, and offspring birthweight. BMC Public Health (2017) 0.75
Methylation of inorganic arsenic by murine fetal tissue explants. Drug Chem Toxicol (2015) 0.75
Exposure to inorganic arsenic can lead to gut microbe perturbations and hepatocellular carcinoma. Acta Pharm Sin B (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ (2000) 9.27
The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene (2010) 4.00
Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA (2008) 3.83
GSK3 signalling in neural development. Nat Rev Neurosci (2010) 3.29
Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci (1998) 2.99
Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina. Int J Epidemiol (1998) 2.92
Gender differences in the disposition and toxicity of metals. Environ Res (2006) 2.91
Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol (2005) 2.90
A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem (2002) 2.85
Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum (2004) 2.50
Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect (2006) 2.50
The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect (2002) 2.48
Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr (2006) 2.41
Arsenic exposure from drinking water and birth weight. Epidemiology (2003) 2.32
The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology (2003) 2.29
Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet (2007) 2.19
Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol (2003) 2.16
Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Mol Cell Biol (2007) 2.15
The developmental origins of adult disease. Eur J Epidemiol (2003) 2.02
A unique metabolism of inorganic arsenic in native Andean women. Eur J Pharmacol (1995) 2.01
Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ Health Perspect (1998) 1.99
Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect (2005) 1.97
School difficulties at adolescence in a regional cohort of children who were extremely low birth weight. Pediatrics (2000) 1.91
Arsenic and cardiovascular disease. Toxicol Sci (2008) 1.90
Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect (2005) 1.88
A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol (2004) 1.88
Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol (2007) 1.86
Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol (2011) 1.84
Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh. Environ Health Perspect (2009) 1.83
Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet. Environ Health Perspect (2011) 1.79
Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ Health Perspect (2007) 1.78
Birth characteristics and hepatoblastoma risk in young children. Cancer (2004) 1.78
Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico. Environ Health (2011) 1.73
Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst (2004) 1.73
Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta (2005) 1.73
Folic acid supplementation lowers blood arsenic. Am J Clin Nutr (2007) 1.70
A quantitative review of mortality and developmental disability in extremely premature newborns. Arch Pediatr Adolesc Med (1998) 1.66
Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. Environ Health Perspect (2007) 1.66
Importance of methyl donors during reproduction. Am J Clin Nutr (2008) 1.62
Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age. Am J Clin Nutr (2007) 1.62
Nucleosomes containing methylated DNA stabilize DNA methyltransferases 3A/3B and ensure faithful epigenetic inheritance. PLoS Genet (2011) 1.56
Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res (2006) 1.55
Elevated placental expression of the imprinted PHLDA2 gene is associated with low birth weight. J Mol Med (Berl) (2006) 1.53
Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol Appl Pharmacol (2005) 1.52
Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1). Proc Natl Acad Sci U S A (2011) 1.52
Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. Chem Res Toxicol (2004) 1.50
Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J Anal At Spectrom (2008) 1.49
Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol (2011) 1.49
Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect (2007) 1.49
Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction. Epigenetics (2010) 1.48
Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect (2012) 1.47
Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect (2008) 1.45
Health effects of early life exposure to arsenic. Basic Clin Pharmacol Toxicol (2008) 1.44
Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am J Epidemiol (2006) 1.43
Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicol Appl Pharmacol (2007) 1.41
Quantitation of in vivo human folate metabolism. Am J Clin Nutr (2004) 1.41
Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol Appl Pharmacol (2009) 1.38
Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol (2006) 1.38
Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicol Appl Pharmacol (2006) 1.37
Influence of prenatal arsenic exposure and newborn sex on global methylation of cord blood DNA. PLoS One (2012) 1.37
The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. Toxicol Appl Pharmacol (2008) 1.35
Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan. Environ Res (2003) 1.34
Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma. Carcinogenesis (2006) 1.33
Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh. Am J Clin Nutr (2007) 1.31
Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch Environ Contam Toxicol (1998) 1.30
Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res (1998) 1.28
Long-term consequences of arsenic poisoning during infancy due to contaminated milk powder. Environ Health (2006) 1.26
Quick sex determination of mouse fetuses. J Neurosci Methods (2000) 1.24
The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J Inorg Biochem (2007) 1.24
Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods (2002) 1.21
Arsenic methylation efficiency increases during the first trimester of pregnancy independent of folate status. Reprod Toxicol (2010) 1.20
The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol (1997) 1.18
Cancer risk among children with very low birth weights. Pediatrics (2009) 1.17
shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. Chem Res Toxicol (2006) 1.17
Nutritional status has marginal influence on the metabolism of inorganic arsenic in pregnant Bangladeshi women. Environ Health Perspect (2008) 1.16
The placenta as a barrier for toxic and essential elements in paired maternal and cord blood samples of South African delivering women. J Environ Monit (2009) 1.16
Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev Dyn (2006) 1.14
Mechanistic insights into folate supplementation from Crooked tail and other NTD-prone mutant mice. Birth Defects Res A Clin Mol Teratol (2009) 1.14
Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. Toxicol Sci (2006) 1.10
Profile of urinary arsenic metabolites during pregnancy. Environ Health Perspect (2003) 1.10
Arsenic speciation transported through the placenta from mother mice to their newborn pups. Environ Res (2006) 1.09
Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology (2006) 1.08
Methylation of arsenic by recombinant human wild-type arsenic (+3 oxidation state) methyltransferase and its methionine 287 threonine (M287T) polymorph: Role of glutathione. Toxicol Appl Pharmacol (2012) 1.07
Segment-specific expression of the neuronatin gene during early hindbrain development. Dev Biol (1995) 1.05
The impact of low birth weight, perinatal conditions, and sociodemographic factors on educational outcome in kindergarten. Pediatrics (1999) 1.04
Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. Toxicol Appl Pharmacol (2001) 1.01
Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure. J Urol (2012) 1.01
A simple HPLC method for the determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues: the effect of vitamin B6 deficiency on these concentrations in rat liver. Biochem Biophys Res Commun (1994) 1.01
Perinatal risk factors for hepatoblastoma. Br J Cancer (2008) 1.01
Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. Int J Mol Sci (2011) 1.00
Functional interactions between the LRP6 WNT co-receptor and folate supplementation. Hum Mol Genet (2010) 1.00
Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues. Metallomics (2011) 0.99
Low-level arsenic exposure, AS3MT gene polymorphism and cardiovascular diseases in rural Texas counties. Environ Res (2012) 0.97
Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. Toxicol Appl Pharmacol (2007) 0.97
The influence of liver disease on the methylation of arsenite in humans. Arch Toxicol (1984) 0.96
Folic Acid supplementation and pregnancy: more than just neural tube defect prevention. Rev Obstet Gynecol (2011) 0.95
Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods (2005) 6.23
The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect (2002) 2.48
Quantitation of choline and its metabolites in tissues and foods by liquid chromatography/electrospray ionization-isotope dilution mass spectrometry. Anal Chem (2002) 2.35
Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J (2005) 2.34
Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr (2002) 2.33
Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology (2010) 2.30
Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials? Exp Biol Med (Maywood) (2008) 2.21
Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J (2006) 2.07
Dietary choline and betaine and the risk of distal colorectal adenoma in women. J Natl Cancer Inst (2007) 2.07
Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype. Environ Health Perspect (2009) 2.02
Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res (2003) 1.99
Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ Health Perspect (2009) 1.98
Requirement of arsenic biomethylation for oxidative DNA damage. J Natl Cancer Inst (2009) 1.96
Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis (2004) 1.91
DNA methylation potential: dietary intake and blood concentrations of one-carbon metabolites and cofactors in rural African women. Am J Clin Nutr (2013) 1.88
Common genetic polymorphisms affect the human requirement for the nutrient choline. FASEB J (2006) 1.88
Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet. Environ Health Perspect (2011) 1.79
Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect (2007) 1.77
Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr (2007) 1.76
Metabolism of arsenic in human liver: the role of membrane transporters. Arch Toxicol (2009) 1.74
Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico. Environ Health (2011) 1.73
Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc Natl Acad Sci U S A (2005) 1.73
Choline availability during embryonic development alters progenitor cell mitosis in developing mouse hippocampus. J Nutr (2003) 1.73
Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp Cell Res (2003) 1.71
Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr (2006) 1.71
Evidence-based criteria in the nutritional context. Nutr Rev (2010) 1.68
Predicting later-life outcomes of early-life exposures. Environ Health Perspect (2012) 1.67
Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype. Environ Health Perspect (2012) 1.66
Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load. Am J Clin Nutr (2005) 1.66
Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China. Environ Health Perspect (2002) 1.65
Epigenetic changes induced by air toxics: formaldehyde exposure alters miRNA expression profiles in human lung cells. Environ Health Perspect (2010) 1.65
A toxicogenomic comparison of primary and photochemically altered air pollutant mixtures. Environ Health Perspect (2011) 1.65
Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol (2004) 1.63
Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J Natl Cancer Inst (2002) 1.61
Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr (2002) 1.60
Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl Pharmacol (2005) 1.59
Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J (2003) 1.59
Diethanolamine induces hepatic choline deficiency in mice. Toxicol Sci (2002) 1.57
Hepatocellular carcinoma associated with liver-gender disruption in male mice. Cancer Res (2007) 1.56
Liver is a target of arsenic carcinogenesis. Toxicol Sci (2008) 1.55
A talin mutant that impairs talin-integrin binding in platelets decelerates αIIbβ3 activation without pathological bleeding. Blood (2014) 1.55
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology (2006) 1.54
Choline- and betaine-defined diets for use in clinical research and for the management of trimethylaminuria. J Am Diet Assoc (2004) 1.53
Chronic cadmium exposure in vitro causes acquisition of multiple tumor cell characteristics in human pancreatic epithelial cells. Environ Health Perspect (2012) 1.53
Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required. J Biol Chem (2004) 1.52
Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol Appl Pharmacol (2005) 1.52
Choline metabolism and risk of breast cancer in a population-based study. FASEB J (2008) 1.51
Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J Anal At Spectrom (2008) 1.49
Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol (2011) 1.49
Systems biology and birth defects prevention: blockade of the glucocorticoid receptor prevents arsenic-induced birth defects. Environ Health Perspect (2013) 1.47
Diethanolamine alters neurogenesis and induces apoptosis in fetal mouse hippocampus. FASEB J (2006) 1.47
Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc Disord (2007) 1.47
Inorganic arsenic and human prostate cancer. Environ Health Perspect (2008) 1.47
Elevated serum creatine phosphokinase in choline-deficient humans: mechanistic studies in C2C12 mouse myoblasts. Am J Clin Nutr (2004) 1.46
Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. Toxicol Appl Pharmacol (2004) 1.44
Early life inorganic lead exposure induces testicular teratoma and renal and urinary bladder preneoplasia in adult metallothionein-knockout mice but not in wild type mice. Toxicology (2010) 1.43
Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology (2007) 1.42
Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environ Health Perspect (2010) 1.42
Nutrition education in U.S. medical schools: latest update of a national survey. Acad Med (2010) 1.42
Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. FASEB J (2007) 1.42
Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro. FASEB J (2002) 1.41
Status of nutrition education in medical schools. Am J Clin Nutr (2006) 1.41
Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicol Appl Pharmacol (2007) 1.41
Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas. J Biol Chem (2011) 1.40
Choline availability modulates human neuroblastoma cell proliferation and alters the methylation of the promoter region of the cyclin-dependent kinase inhibitor 3 gene. J Neurochem (2004) 1.40
Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2. Free Radic Biol Med (2008) 1.39
Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol Appl Pharmacol (2009) 1.38
Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol (2006) 1.37
Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice. J Nutr (2003) 1.36
Folic acid deficiency during late gestation decreases progenitor cell proliferation and increases apoptosis in fetal mouse brain. J Nutr (2004) 1.35
Rat liver sinusoidal endothelial cells survive without exogenous VEGF in 3D perfused co-cultures with hepatocytes. FASEB J (2007) 1.35
Cadmium-induced cancers in animals and in humans. Int J Occup Environ Health (2007) 1.35
Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Toxicol Sci (2003) 1.35
Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 mice. Toxicol Sci (2010) 1.33
Second trimester folate status and preterm birth. Am J Obstet Gynecol (2004) 1.32
Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic Biol Med (2007) 1.31
Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure. Environ Health Perspect (2006) 1.30
Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine. Chem Res Toxicol (2004) 1.27
Perinatal choline influences brain structure and function. Nutr Rev (2006) 1.26
Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst (2010) 1.24
Differential activation of AP-1 in human bladder epithelial cells by inorganic and methylated arsenicals. FASEB J (2002) 1.22
Choline deficiency alters global histone methylation and epigenetic marking at the Re1 site of the calbindin 1 gene. FASEB J (2009) 1.21
Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect (2007) 1.21
Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis. Int J Cancer (2005) 1.21
Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation. J Biochem Mol Toxicol (2013) 1.19